Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Corneal Conditions
Diabetes Eye Disease
Dry Eye
Eye Disorders
Eye trauma
Macular Degeneration
Media Relations
New Doctor
Plastic surgery
Retina care
Retinal Disorders

Articles Featuring Dr. Charles Mayron

Below is a video and several informative articles featuring Dr. Mayron, prior to his joining Ophthalmic Consultants.


Optos – Video

Watch the Video

In this video interview, Dr. Mayron discusses how the Optos retinal imaging machine enhances his work as a vitreoretinal specialist. The Optos features detailed image capture, which gives specialists more information about the eye’s structure and any pathology present.

Dr. Mayron explains the Optos captures a big picture resolution as clear and detailed as his view in the operating room. One notable benefit of this machine is that it doesn’t require dilation of patients’ eyes (which saves physicians time and increases patients’ comfort). 

Also, Optos is exceptional at detecting early signs of damage to the peripheral retina, retinal tears, and early retinal detachments. These detailed images make it easy to talk about each patient’s diagnosis and support effective treatment. 


The use of the Optos technology is the standard of care at Ophthalmic Consultants.


Iluvien Implant – Times Union Article

Read the article

Dr. Mayron discusses an innovative eye implant option to correct diabetic macular degeneration. This case study was a 70-year-old female patient with macular edema (or swollen retina) and steadily losing sight. 

Laser treatments and monthly injections (anti-VEGF drugs and another steroid) did not improve her eyesight. Therefore, Dr. Mayron implanted an Iluvien implant, which releases steroids into the eye to reduce inflammation. This implant is smaller than a grain of rice; it is insoluble but comfortable and lasts for three years. The patient experienced sight restoration within 30 days and was able to drive again. 

However, Dr. Mayron cautions that the Iluvien implant is not a panacea for every macular edema case. Some side effects may include cataracts or glaucoma, so it’s not a first-line treatment option. But it is an effective treatment for those with severe vision loss and for whom other treatments have not worked. 

“It’s second- or third-line therapy for diabetic macular edema,” Mayron said. “These are people who have either failed first-line therapy, or the treatment burden has become impossible.”

Early signs of diabetic macular degeneration include macular edema and blurred vision. Even with disease onset, if people with diabetes keep their blood sugar in check, they can slow the condition’s progression. 

The Iluvien implant costs close to $9000, but the manufacturer, Alimera Sciences provides financial assistance to patients who can’t cover the implant’s cost. Some state-based insurance companies may also subsidize the implant, making it accessible to those who need it.  


The use of Iluvien implant technology is the standard of care at Ophthalmic Consultants for complex macular conditions.


Iluvien Implant – Article written by Dr. Mayron

Read the article

Diabetic macular edema (DME) is usually treated with monthly, time- and money-consuming anti-VEGF medications and corticosteroids. Yet, these options are often ineffective. 

The FDA approved the Iluvien implant in 2014 to treat these conditions over three years. This 0.19 mg fluocinolone acetonide intravitreal implant is tinier than a grain of rice and placed in the eye, slowly releases medication over time to reduce eye inflammation and increase vision. 

An optometrist carefully examines each patient with an optomap to document the eyes’ condition before the Iluvien implant is set in place and afterward. The optomap technology helps to guide the implantation process. Medical experts advocate the verification of all Iluvien implants for best results. 


The use of Iluvien implant technology is the standard of care at Ophthalmic Consultants for complex macular conditions..

Iluvien Implant – CBS6 Television Story

A breakthrough technology in treating diabetic macular degeneration with an innovative eye implant option.

Watch the TV segment

The use of Iluvien implant technology is the standard of care at Ophthalmic Consultants for complex macular conditions..


MicroPulse Article

Read the Case Report

Dr. Mayron explores using MicroPulse as an alternate treatment for diabetic eye conditions when anti-VEGF injections and traditional thermal laser treatments aren’t suitable or completely effective. 

He uses MicroPulse laser therapy to deliver effective treatment without the risk of damaging any delicate retinal tissue. Scientific research specifies the safety of subthreshold photostimulation treatments to resolve eye conditions. This technology makes it safer to operate around the fovea (the part of the retina responsible for high-acuity vision). 

MicroPulse is not only more effective, but it is also less invasive compared to anti-VEGF treatment. It is helpful as a first-line, standalone therapy, or as an accompaniment to anti-VEGF injections. Treatment choice often depends on the severity of a patient’s symptoms and central retinal thickness (CRT). 

Dr. Mayron advocates using anti-VEGF and MicroPulse to treat symptomatic visual acuity and CRT. An extra benefit of combining both options to treat DME is the possible reduction in injections, which minimizes the treatment burden and costs. MicroPulse is suitable for monotherapy (or standalone treatment) for patients with minimal foveal edema and mild symptoms.

A 77-year-old male patient with DME wasn’t responding to anti-VEGF injections. Dr. Mayron recommended MicroPulse to eliminate retinal fluid, and two months later, his vision improved. After four MicroPulse treatments, the patient had no DME and, most importantly, showed no evidence of foveal damage. 

MicroPulse is useful for treating DME and central serous chorioretinopathy, macular edema arising from vein occlusion, and some cases of age-related macular degeneration (AMD). This treatment is effective because it can be safely repeated, and patients report improvement in vision over time. Also, this therapy is highly accurate, efficient, and integrates well with traditional laser technologies. 


The use of MicroPulse technology is one of the standards of care at Ophthalmic Consultants.

Call Now Button